Jaime Xinos
Vermogen: 590 990 $ op 31-08-2026
Vermogen: 590 990 $ op 31-08-2026
Jaime Xinos worked at OncoGenex Pharmaceuticals, Inc. as Senior Director-Global Oncology Commercial from 2010 to 2017.
Ms. Xinos worked at Achieve Life Sciences, Inc. as Chief Commercial Officer from 2024 to 2026.
Ms. Xinos completed undergraduate and MBA degrees at the University of Illinois.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-05-2026 | 74.432 ( 0,07% ) | 590 990 $ | 31-08-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. | Corporate Officer/Principal | 31-05-2026 |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Public Communications Contact | 01-01-2010 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
University of Illinois
University of Illinois Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoGenex Pharmaceuticals, Inc.
OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies that address treatment resistance in cancer patients | Health Technology |
Achieve Life Sciences, Inc.
Achieve Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cytisinicline for smoking cessation and nicotine addiction | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau